Home
How It Works
Solutions
For Academic Experts
Resources
Events
Blog
Case Studies
Request Demo
Sign Up
Login

Work with thought leaders and academic experts in gastroenterology

Companies can greatly benefit from collaborating with academic researchers in the field of Gastroenterology. These experts can provide valuable insights, research, and expertise to enhance various aspects of a company's operations. Here are some ways companies can collaborate with Gastroenterology researchers:

Experts on NotedSource with backgrounds in gastroenterology include Roshonda Jones, Dr. Abbas Poorhashemi, Luke Connelly, Marina Baretti, Kayvan Najarian, Jonathan Moore, Matthew Laye, Ph.D., Mehrdad Sheikhvatan, John Joe, Marian Grendar, Ph.D., and Brian Frank.

Roshonda Jones

Charlotte, North Carolina, United States of America
Bioinformatics research scientist using computational and statistical techniques to examine the relationship between diet, health and microbes
Most Relevant Research Interests
Gastroenterology
Other Research Interests (28)
Bioinfomatics
Microbiome
Childhood Obesity
Microbiology
Microbiology (medical)
And 23 more
About
Roshonda Jones is an experienced bioinformatics and computational biologist with a passion for exploring the complexities of life. She earned her Ph.D. in Bioinformatics and Computational Biology from University of North Carolina at Charlotte in 2016, and went on to complete a postdoctoral fellowship at USC, as well as a postdoctoral research fellowship at Children’s Hospital Los Angeles. Her research interests include machine learning and bioinformatics. She is committed to using her expertise to further scientific knowledge and advance the field.
Most Relevant Publications (5+)

43 total publications

Mouse Paneth cell antimicrobial function is independent of Nod2

Gut / Mar 19, 2013

Shanahan, M. T., Carroll, I. M., Grossniklaus, E., White, A., von Furstenberg, R. J., Barner, R., Fodor, A. A., Henning, S. J., Sartor, R. B., & Gulati, A. S. (2013). Mouse Paneth cell antimicrobial function is independent of Nod2. Gut, 63(6), 903–910. https://doi.org/10.1136/gutjnl-2012-304190

High intake of dietary fructose in overweight/obese teenagers associated with depletion of Eubacterium and Streptococcus in gut microbiome

Gut Microbes / Apr 16, 2019

Jones, R. B., Alderete, T. L., Kim, J. S., Millstein, J., Gilliland, F. D., & Goran, M. I. (2019). High intake of dietary fructose in overweight/obese teenagers associated with depletion of Eubacterium and Streptococcus in gut microbiome. Gut Microbes, 10(6), 712–719. https://doi.org/10.1080/19490976.2019.1592420

Early life gut microbiota is associated with rapid infant growth in Hispanics from Southern California

Gut Microbes / Jan 01, 2021

Alderete, T. L., Jones, R. B., Shaffer, J. P., Holzhausen, E. A., Patterson, W. B., Kazemian, E., Chatzi, L., Knight, R., Plows, J. F., Berger, P. K., & Goran, M. I. (2021). Early life gut microbiota is associated with rapid infant growth in Hispanics from Southern California. Gut Microbes, 13(1). https://doi.org/10.1080/19490976.2021.1961203

Lactose-reduced infant formula with added corn syrup solids is associated with a distinct gut microbiota in Hispanic infants

Gut Microbes / Sep 04, 2020

Jones, R. B., Berger, P. K., Plows, J. F., Alderete, T. L., Millstein, J., Fogel, J., Iablokov, S. N., Rodionov, D. A., Osterman, A. L., Bode, L., & Goran, M. I. (2020). Lactose-reduced infant formula with added corn syrup solids is associated with a distinct gut microbiota in Hispanic infants. Gut Microbes, 12(1), 1813534. https://doi.org/10.1080/19490976.2020.1813534

Sa1801 Local Environmental Conditions Override NOD2-Mediated Regulatory Effects on Mouse Intestinal Microbial Composition

Gastroenterology / May 01, 2013

Carroll, I. M., Shanahan, M. T., Barner, R., Fodor, A. A., Sartor, R. B., & Gulati, A. S. (2013). Sa1801 Local Environmental Conditions Override NOD2-Mediated Regulatory Effects on Mouse Intestinal Microbial Composition. Gastroenterology, 144(5), S-309. https://doi.org/10.1016/s0016-5085(13)61112-9

Dr. Abbas Poorhashemi

Toronto, Ontario, Canada
Dr. Poorhashemi is the President of the Canadian Institute for International Law Expertise (CIFILE). He is an academic and expert in international law.
Most Relevant Research Interests
Gastroenterology
Other Research Interests (16)
International Law
International Environmental Law
Sensory Systems
Physiology
Museology
And 11 more
About
Public International Law, International Criminal Law, International Environmental Law, Comparative Law
Most Relevant Publications (1+)

4 total publications

Accéder aux publications académiques et à votre profil de citations en utilisant Google Scholar

Management et ingénierie de l'innovation / Dec 01, 2014

DOU, H. (2014). Accéder aux publications académiques et à votre profil de citations en utilisant Google Scholar. Management et Ingénierie de l’innovation. https://doi.org/10.51257/f-1398

Luke Connelly

Professor of Health Economics, The University of Queensland, CBEH
Most Relevant Research Interests
Gastroenterology
Other Research Interests (51)
Health economics
insurance
Public Health, Environmental and Occupational Health
Safety, Risk, Reliability and Quality
Human Factors and Ergonomics
And 46 more
About
Luke Connelly is Professor of Health Economics at the Centre for the Business and Economics of Health. He also holds a Professorial appointment (part-time) at The University of Bologna, to which he was appointed in 2017 via the Italian “Direct Call” ([link](https://www.unibo.it/sitoweb/luke.connelly/en)) process. In 2019 he was appointed as Honorary Professor at The University of Sydney. His main interests are in health economics and insurance economics and the effects of institutions (including legal constructs) on incentives and behaviour. He has also worked in other fields of applied microeconomics, including education economics and transport economics. His publications include papers in *Review of Income and Wealth*, *Health Economics*, *Journal of Health Economics*, *Journal of Risk and Insurance*, *Geneva Papers on Risk and Insurance*, *Accident Analysis and Prevention*, *Journal of Law and Medicine*, *Journal of Clinical Epidemiology*, *European Journal of Health Economics*, *International Journal of Health Economics and Finance*, *Social Science and Medicine*, *Economic Papers*, *Economic Analysis and Policy*, *Journal of Transport Economics and Policy*, *Labour Economics*, *Economics and Human Biology* as well as in a range of clinical journals, including *Lancet*. Luke has served on a number of public committees including the Medical Services Advisory Committee (MSAC), which advises the Australian Minister for Health on the safety, efficacy, effectiveness, and cost-effectiveness of new and extant listings on Australia's Medicare Benefits Schedule. He has extensive service on other public committees and taskforces as well as extensive teaching and consulting engagements with industry. Over his career he has been a chief investigator on research grants and contracts totalling more than $67m. He is a member of the Editorial Boards of European Journal of Health Economics and the International Journal on Environmental Research and Public Health. He is a member of the International Health Economics Association's Arrow Awards Committee, which awards an annual prize in honour of Nobel Laureate Kenneth Arrow for the best paper in the field. He is currently Guest Editor (with Christophe Courbage) on a Special Issue of the Geneva Papers on Risk and Insurance on Insurance and Emerging Health Risks. His current research interests include health service innovations to improve the health of people with chronic kidney disease(CKD). Ongoing interests include the economics of disability and insurance, compensable injury compensation schemes, and the determinants of health. Luke enjoys and has considerable experience teaching economics and health economics at both the graduate and undergraduate levels. In 2014 he was awarded the School of Economics Distinguished Teaching Award for his teaching on UQ's Master of Health Economics Program. In July 2016 and July 2019 he also taught summer schools in Health Economics and the Economics of Insurance at The University of Lucerne, Switzerland. Over the past 10 years he has been a chief investigator on grants totalling more than $70m.
Most Relevant Publications (1+)

105 total publications

Economic evaluation of fecal microbiota transplantation for the treatment of recurrentClostridium difficileinfection in Australia

Journal of Gastroenterology and Hepatology / Nov 29, 2016

Merlo, G., Graves, N., Brain, D., & Connelly, L. B. (2016). Economic evaluation of fecal microbiota transplantation for the treatment of recurrentClostridium difficileinfection in Australia. Journal of Gastroenterology and Hepatology, 31(12), 1927–1932. Portico. https://doi.org/10.1111/jgh.13402

Marina Baretti

Baltimore, Maryland, United States of America
I am a clinical translational researcher in gastrointestinal (GI) oncology, collaborating closely with laboratory-based researchers to move laboratory findings into patients and to answer important clinical questions.
Most Relevant Research Interests
Gastroenterology
Other Research Interests (15)
Oncology
Pharmacology (medical)
Pharmacology
Hematology
Hepatology
And 10 more
About
Throughout my training, I have been focused toward my ultimate goal of becoming a clinical translational researcher in gastrointestinal (GI) oncology, collaborating closely with laboratory-based researchers to move laboratory findings into patients and to answer important clinical questions. My clinical research is centered on the development of novel agents in GI cancers, with particular interest in combinatorial approaches of epigenetic therapies and immunotherapies combinations. I ran the first phase II study of combination epigenetic therapy and immunotherapy in advanced pancreatic adenocarcinoma and cholangiocarcinoma, working with a collaborative team that incorporates leading experts in cancer immunology, epigenetics and drug development. I was awarded the 2018 ASCO Conquer Cancer Foundation Young Investigator Award for this project.  Together with Dr. Yarchoan, we are running a clinical trial of a novel neoantigen-specific vaccine in combination with immune checkpoint inhibitors for advanced fibrolamellar carcinoma (FLC) (NCT04248569). My laboratory focus has been on developing and validating a preclinical mouse model of FLC to investigate mechanisms underlying FLC pathogenesis, and will become a critical tool for investigating novel therapeutic strategies in FLC.
Most Relevant Publications (3+)

57 total publications

Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer

Digestive and Liver Disease / Oct 01, 2015

Sefrioui, D., Sarafan-Vasseur, N., Beaussire, L., Baretti, M., Gangloff, A., Blanchard, F., Clatot, F., Sabourin, J.-C., Sesboüé, R., Frebourg, T., Michel, P., & Di Fiore, F. (2015). Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer. Digestive and Liver Disease, 47(10), 884–890. https://doi.org/10.1016/j.dld.2015.05.023

Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study

Clinical Colorectal Cancer / Sep 01, 2018

Baretti, M., Rimassa, L., Personeni, N., Giordano, L., Tronconi, M. C., Pressiani, T., Bozzarelli, S., & Santoro, A. (2018). Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study. Clinical Colorectal Cancer, 17(3), e489–e498. https://doi.org/10.1016/j.clcc.2018.03.010

Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications

Gastric Cancer / Aug 16, 2016

Personeni, N., Baretti, M., Bozzarelli, S., Spaggiari, P., Rubino, L., Tronconi, M. C., Fumagalli Romario, U., Rosati, R., Giordano, L., Roncalli, M., Santoro, A., & Rimassa, L. (2016). Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications. Gastric Cancer, 20(3), 428–437. https://doi.org/10.1007/s10120-016-0625-1

Kayvan Najarian

Professor of Comp Med and Bioinf, Emergency Med, and Electrical and Comp Engineering
Most Relevant Research Interests
Gastroenterology
Other Research Interests (59)
biomedical inforamtics
bioinformatics
singal processing
image processing
machine learning
And 54 more
Most Relevant Publications (1+)

106 total publications

Fully automated endoscopic disease activity assessment in ulcerative colitis

Gastrointestinal Endoscopy / Mar 01, 2021

Yao, H., Najarian, K., Gryak, J., Bishu, S., Rice, M. D., Waljee, A. K., Wilkins, H. J., & Stidham, R. W. (2021). Fully automated endoscopic disease activity assessment in ulcerative colitis. Gastrointestinal Endoscopy, 93(3), 728-736.e1. https://doi.org/10.1016/j.gie.2020.08.011

Jonathan Moore

Genome edit designer
Most Relevant Research Interests
Gastroenterology
Other Research Interests (55)
Data science
Genome editing
Bioinformatics
Evolution
Biodiversity
And 50 more
Most Relevant Publications (1+)

72 total publications

PWE-254 Is the macroscopically normal mucosa (MNM) around colorectal cancer really ‘normal’?: Abstract PWE-254 Table 1

Gut / Jun 01, 2015

Patel, A., Fang, Y., Moore, J., Williams, N., Tripathi, G., & Arasaradnam, R. (2015). PWE-254 Is the macroscopically normal mucosa (MNM) around colorectal cancer really ‘normal’?: Abstract PWE-254 Table 1. Gut, 64(Suppl 1), A324.2-A325. https://doi.org/10.1136/gutjnl-2015-309861.700

Matthew Laye, Ph.D.

Medical Physiology Teacher, Data Scientist, Endurance Coach, Wearable Technology Consultant, Writer About Research
Most Relevant Research Interests
Gastroenterology
Other Research Interests (24)
Physiology
Hepatology
Physiology (medical)
Multidisciplinary
Public Health, Environmental and Occupational Health
And 19 more
Most Relevant Publications (4+)

53 total publications

Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats

American Journal of Physiology-Gastrointestinal and Liver Physiology / Mar 01, 2008

Rector, R. S., Thyfault, J. P., Morris, R. T., Laye, M. J., Borengasser, S. J., Booth, F. W., & Ibdah, J. A. (2008). Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats. American Journal of Physiology-Gastrointestinal and Liver Physiology, 294(3), G619–G626. https://doi.org/10.1152/ajpgi.00428.2007

T1620 Loss of Mitochondrial Content and Function Contribute to the Natural History of Nonalcoholic Fatty Liver Disease in a Hyperphagic Obese Rodent Model

Gastroenterology / May 01, 2009

Rector, S., Thyfault, J. P., Uptergrove, G. M., Morris, E. M., Naples, S. P., Borengasser, S. J., Mikus, C. R., Laye, M. J., Laughlin, M. H., Booth, F. W., & Ibdah, J. A. (2009). T1620 Loss of Mitochondrial Content and Function Contribute to the Natural History of Nonalcoholic Fatty Liver Disease in a Hyperphagic Obese Rodent Model. Gastroenterology, 136(5), A-850. https://doi.org/10.1016/s0016-5085(09)63920-2

S1894 Physical Activity and Short-Term Inactivity Modulate Hepatic Fatty Acid Oxidation and Lipogenesis Proteins in Otsuka Long-Evans Tokushima Fatty (Oletf) Rats

Gastroenterology / Apr 01, 2008

Rector, S., Thyfault, J. P., Laye, M. J., Morris, R. T., Borengasser, S. J., Uptergrove, G. M., Booth, F. W., & Ibdah, J. A. (2008). S1894 Physical Activity and Short-Term Inactivity Modulate Hepatic Fatty Acid Oxidation and Lipogenesis Proteins in Otsuka Long-Evans Tokushima Fatty (Oletf) Rats. Gastroenterology, 134(4), A-778-A-779. https://doi.org/10.1016/s0016-5085(08)63636-7

S1894 Physical Activity and Short-Term Inactivity Modulate Hepatic Fatty Acid Oxidation and Lipogenesis Proteins in Otsuka Long-Evans Tokushima Fatty (Oletf) Rats

Gastroenterology / Apr 01, 2008

Rector, S., Thyfault, J. P., Laye, M. J., Morris, R. T., Borengasser, S. J., Uptergrove, G. M., Booth, F. W., & Ibdah, J. A. (2008). S1894 Physical Activity and Short-Term Inactivity Modulate Hepatic Fatty Acid Oxidation and Lipogenesis Proteins in Otsuka Long-Evans Tokushima Fatty (Oletf) Rats. Gastroenterology, 134(4), A-778-A-779. https://doi.org/10.1016/s0016-5085(08)63636-7

Mehrdad Sheikhvatan

Iran University of Medical Sciences
Most Relevant Research Interests
Gastroenterology
Other Research Interests (55)
Molecular Cardiogenetic
Obstetrics and Gynecology
Neurology (clinical)
Otorhinolaryngology
Hepatology
And 50 more
Most Relevant Publications (6+)

90 total publications

Hepatobiliary & Pancreatic Diseases International (HBPD INT)

Hepatobiliary & Pancreatic Diseases International / Aug 01, 2014

Hepatobiliary & Pancreatic Diseases International (HBPD INT). (2014). Hepatobiliary & Pancreatic Diseases International, 13(4), A2. https://doi.org/10.1016/s1499-3872(14)60287-3

Comparison of the efficacy of intravenous tranexamic acid with and without topical administration versus placebo in urgent endoscopy rate for acute gastrointestinal bleeding: A double-blind randomized controlled trial

United European Gastroenterology Journal / Jun 20, 2017

Tavakoli, N., Mokhtare, M., Agah, S., Azizi, A., Masoodi, M., Amiri, H., Sheikhvatan, M., Syedsalehi, B., Behnam, B., Arabahmadi, M., & Mehrazi, M. (2017). Comparison of the efficacy of intravenous tranexamic acid with and without topical administration versus placebo in urgent endoscopy rate for acute gastrointestinal bleeding: A double-blind randomized controlled trial. United European Gastroenterology Journal, 6(1), 46–54. https://doi.org/10.1177/2050640617714940

The efficacy of Helicobacter pylori eradication regimen with and without vitamin C supplementation

Digestive and Liver Disease / Sep 01, 2009

Zojaji, H., Talaie, R., Mirsattari, D., Haghazali, M., Molaei, M., Mohsenian, N., Derakhshan, F., & Zali, M. R. (2009). The efficacy of Helicobacter pylori eradication regimen with and without vitamin C supplementation. Digestive and Liver Disease, 41(9), 644–647. https://doi.org/10.1016/j.dld.2008.09.008

Validity and reliability of the Japanese version of the Patient Assessment of Constipation Quality of Life questionnaire

Journal of Gastroenterology / May 09, 2013

Nomura, H., Agatsuma, T., & Mimura, T. (2013). Validity and reliability of the Japanese version of the Patient Assessment of Constipation Quality of Life questionnaire. Journal of Gastroenterology, 49(4), 667–673. https://doi.org/10.1007/s00535-013-0825-y

Perforated peptic ulcer disease: mid-term outcome among Iranian population

The Turkish Journal of Gastroenterolog / Jun 01, 2010

KAMANI, F., MOGHIMI, M., MARASHI, S. A., PEYROVI, H., & SHEIKHVATAN, M. (2010). Perforated peptic ulcer disease: mid-term outcome among Iranian population. The Turkish Journal of Gastroenterolog, 21(2), 125–128. https://doi.org/10.4318/tjg.2010.0069

The Efficacy and Tolerability of Mebeverine in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials

Gastroenterology / Apr 01, 2017

Mokhtare, M., Boghratian, A., Agah, S., & Sheikhvatan, M. (2017). The Efficacy and Tolerability of Mebeverine in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials. Gastroenterology, 152(5), S719–S720. https://doi.org/10.1016/s0016-5085(17)32503-9

John Joe

Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK
Most Relevant Research Interests
Gastroenterology
Other Research Interests (68)
microbiology
systems biology
genetics
quantum biology
Management of Technology and Innovation
And 63 more
Most Relevant Publications (4+)

95 total publications

Specific detection of Mycobacterium paratuberculosis DNA associated with granulomatous tissue in Crohn's disease.

Gut / Apr 01, 1994

Fidler, H. M., Thurrell, W., Johnson, N. M., Rook, G. A., & McFadden, J. J. (1994). Specific detection of Mycobacterium paratuberculosis DNA associated with granulomatous tissue in Crohn’s disease. Gut, 35(4), 506–510. https://doi.org/10.1136/gut.35.4.506

Quadruple antimycobacterial chemotherapy in Crohn's disease: results at 9 months of a pilot study in 20 patients

Alimentary Pharmacology & Therapeutics / Mar 31, 2007

HAMPSON, S. J., PARKER, M. C., SAVERYMUTTU, S. H., JOSEPH, A. E., MCFADDEN, J.-J. P., & HERMON-TAYLOR, J. (2007). Quadruple antimycobacterial chemotherapy in Crohn’s disease: results at 9 months of a pilot study in 20 patients. Alimentary Pharmacology & Therapeutics, 3(4), 343–352. https://doi.org/10.1111/j.1365-2036.1989.tb00221.x

Investigation of mycobacteria in Crohn's disease tissue by Southern blotting and DNA hybridisation with cloned mycobacterial genomic DNA probes from a Crohn's disease isolated mycobacteria.

Gut / Sep 01, 1988

Butcher, P. D., McFadden, J. J., & Hermon-Taylor, J. (1988). Investigation of mycobacteria in Crohn’s disease tissue by Southern blotting and DNA hybridisation with cloned mycobacterial genomic DNA probes from a Crohn’s disease isolated mycobacteria. Gut, 29(9), 1222–1228. https://doi.org/10.1136/gut.29.9.1222

Mycobacteria and Crohn's disease.

Gut / Aug 01, 1988

Hampson, S. J., McFadden, J. J., & Hermon-Taylor, J. (1988). Mycobacteria and Crohn’s disease. Gut, 29(8), 1017–1019. https://doi.org/10.1136/gut.29.8.1017

Marian Grendar, Ph.D.

Most Relevant Research Interests
Gastroenterology
Other Research Interests (66)
Hepatology
Cancer Research
Oncology
Physical Therapy, Sports Therapy and Rehabilitation
Orthopedics and Sports Medicine
And 61 more
Most Relevant Publications (1+)

117 total publications

Gastrointestinal sequalae months after severe acute respiratory syndrome corona virus 2 infection: a prospective, observational study

European Journal of Gastroenterology & Hepatology / Jul 27, 2022

Liptak, P., Duricek, M., Rosolanka, R., Ziacikova, I., Kocan, I., Uhrik, P., Grendar, M., Hrnciarova, M., Bucova, P., Galo, D., & Banovcin, P. (2022). Gastrointestinal sequalae months after severe acute respiratory syndrome corona virus 2 infection: a prospective, observational study. European Journal of Gastroenterology & Hepatology, 34(9), 925–932. https://doi.org/10.1097/meg.0000000000002425

Brian Frank

Most Relevant Research Interests
Gastroenterology
Other Research Interests (1)
Internal Medicine

Example gastroenterology projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on gastroenterology?

New Product Development

Collaborating with a Gastroenterology researcher can help companies develop new products related to digestive health. These researchers can provide valuable insights into the needs and preferences of patients, leading to the development of innovative and effective solutions.

Clinical Trials and Research Studies

Gastroenterology researchers can play a crucial role in conducting clinical trials and research studies for companies. Their expertise in designing and implementing studies, analyzing data, and interpreting results can contribute to the development of new treatments, medications, and diagnostic tools.

Consulting and Advisory Services

Companies can benefit from the consulting and advisory services of Gastroenterology researchers. These experts can provide guidance on regulatory compliance, market trends, and strategic decision-making, helping companies navigate the complex landscape of the healthcare industry.

Data Analysis and Insights

Gastroenterology researchers are skilled in analyzing large datasets related to digestive health. By collaborating with these experts, companies can gain valuable insights into patient demographics, treatment outcomes, and disease patterns, enabling them to make data-driven decisions and improve their products and services.

Educational and Training Programs

Companies can collaborate with Gastroenterology researchers to develop educational and training programs for healthcare professionals. These programs can enhance the knowledge and skills of medical practitioners, leading to improved patient care and better outcomes.